Yuyu Pharma, Inc.

KOSE:A000220 Stock Report

Market Cap: ₩70.8b

Yuyu Pharma Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Yuyu Pharma.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth38.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance

Aug 24
Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance

Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now

Aug 07
Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now

Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden

Apr 02
Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden

Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?

Mar 08
Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?

The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More

Feb 10
The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More

We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide

Jan 07
We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide

Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly

Dec 20
Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly

Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?

Dec 03
Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Yuyu Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSE:A000220 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2024135,2811,72612,34417,073N/A
3/31/2024136,320-2,810-2,4284,060N/A
12/31/2023137,210-7,207-4,685421N/A
9/30/2023137,340-8,446-17,355-10,972N/A
6/30/2023137,391-7,801-16,816-11,215N/A
3/31/2023137,649-5,812-13,548-8,346N/A
12/31/2022138,881-6,273-11,797-6,229N/A
9/30/2022135,290-5,811-12,133-5,813N/A
6/30/2022130,931-4,311-9,998-1,742N/A
3/31/2022124,686-3,069-2,2605,739N/A
12/31/2021115,655-2,499-2,2424,509N/A
9/30/2021109,174-1,248-1,3014,699N/A
6/30/2021104,89121-4,2101,115N/A
3/31/2021101,381-880-13,269-2,560N/A
12/31/202098,120999-16,735-2,669N/A
9/30/202097,9372,843-10,6204,576N/A
6/30/202093,9773,174-8,6758,514N/A
3/31/202091,9585,335-30211,775N/A
12/31/201990,8784,4374,66313,185N/A
9/30/201988,4663,9423,4119,592N/A
6/30/201986,3023,399-4166,765N/A
3/31/201983,7603,164-3,2096,032N/A
12/31/201883,0963,748-3,9606,110N/A
12/31/201783,7805,975N/A561N/A
9/30/201781,4046,224N/A4,604N/A
6/30/201776,7376,648N/A6,656N/A
3/31/201771,5795,640N/A9,816N/A
12/31/201671,2484,359N/A11,166N/A
9/30/201669,3523,394N/A262N/A
6/30/201670,080927N/A-3,158N/A
3/31/201669,743-253N/A-11,684N/A
12/31/201566,259-8,316N/A-12,040N/A
9/30/201565,621-7,952N/A-5,603N/A
6/30/201564,739-6,832N/A-3,121N/A
3/31/201562,816-7,467N/A1,363N/A
12/31/201461,9201,535N/A1,281N/A
9/30/201460,893881N/A1,360N/A
6/30/201459,795400N/A229N/A
3/31/201461,9941,877N/A-775N/A
12/31/201362,6513,202N/A1,558N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A000220's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A000220's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A000220's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A000220's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A000220's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A000220's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y